Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in thai patients with peptic ulcer disease

Journal of the Medical Association of Thailand

Volumn 84, Issue SUPPL. 1, 2001, Pages

  Wongkusoltham, Pongsit ^a   Vilaichone, Ratha Korn ^a   Kullavanijaya, Pinit ^a   Phaosawadi, Kumthorn ^b   Mahachai, Varocha ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Vichaiyut Hospital   (Thailand)

Author keywords

Helicobacter Pyloli; Metronidazole; Peptic Ulcer Disease

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PEPTIC ULCER; STOMACH BIOPSY; THAILAND;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CLARITHROMYCIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OMEPRAZOLE; PROBABILITY; PROSPECTIVE STUDIES; STOMACH ULCER; THAILAND; TREATMENT OUTCOME;

EID: 0034815163     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Eng J Med 1991; 324: 1043-8.
2. Veldhuyzen van Zanten SJ, Sheman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia : a systematic overview. Can Med Assoc J 1994; 150: 177-85.
3. Graham DY, Lew GM, Klein PD. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric and duodenal ulcer. Ann Intern Med 1992; 116: 705-8.
4. Graham DY, Hepps KS, Raminez FC. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-42.
5. NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
6. Howden CW. For which conditions are there evidence-based justification for the treatment of H. pylori infection? Gastroenterology 1997; 113 (Supp 16): S107-12.
7. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
8. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12.
9. Glupczynski Y. In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents-basis for treatment or microbiologists'obsession? Intern J Med Microbiol Virol Parasitol Infect Dis 1993; 280: 227-38.
10. Bazzoli F. My approach to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 1999; 11 (Suppl I): S37-S41.
11. Phaosawasdi K, Chutaputti A, Ratanalert S. Susceptibility of clinical isolates of Helicobacter pylori from Thai patients to seven antimicrobial agents. J Infect Dis Antimicrob 1995; 12: 111-4.
12. Seppala K, Farkkila M, Nuutinen H. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol 1992; 27: 973-6.
13. Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance : a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996; 11: 290-2.
14. Rautelin H, Seppala K, Renkonen OV. Role of metronidazole resistance in therapy of Helicobacter pylori infeciton. Antimicrob Chemother 1992; 36: 163-6.
15. Bell GD, Powell KU, Burridge SM. Helicobacter pylori: efficacy and side effect profile of a comnination of omeprazole, amoxicillin and metronidazole compared with four alternative regimens. Q J Med 1993; 86: 743-50.
16. Noach LA, Langenberg WL, Bertola MA. Impact of metronidazole on the eradication of Helicobacter pylori. Scand J Infect Dis 1994; 26: 321-7
17. Peitz U. High cure rate of H. pylori infection by one-week therapy with omeprazole, and clarithromycin despite a negative impact by metronidazole resistance. Gut 1996; 39 (Suppl 2): A5. (Abstract)
18. Gisbert JP. Which factors influence on the success of "classic" triple therapy in Helicobactor pylori eradication? Gut 1996; 39 (Suppl 2): A5.
19. Moayyedi P. Prelevance of metronidazole resistance in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. Gut 1996; 39 (Suppl): A5.
20. Whitehead M. Metronidazole resistance and H. pylori eradication. Gut 1996; 38 (Suppl 1): A2. (Abstract)
21. Megraud F, Doermann HP. Clinical relevance of resistant strains of Hellicobacter pylori: a rebiew of current data. Gut 1998; 43 (Suppl 1): S61-S65.
22. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5
23. Goddard AF, Jessa MJ, Barrett DA. Effect of Omeprazole on the Distribution of Metronidazole, Amoxicillin and Clarithromycin in Human Gastric Juice. Gastroenterology 1996; 111: 358-67.
24. nd ed. Oxford, England: Blackwell, 1992.
25. Goddwin CS, McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. Gastroenterol Clin Biol 1989; 13 (1 Pt 1): 96B-100B.
26. Hardy DJ, Hanson CW, Hensey DM. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother 1988; 22: 631-36.
27. Gryson ML, Eliopoulos GM, Rerraro MJ. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 10: 888-9
28. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 (Suppl 1): 43-53.
29. Graham DY, de Boer WA, Tytgat GNJ. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 1996; 91: 1072-6.
30. Owin RJ, Bell GD, Desai M, Moreno M, Gant PW. Biotype and molecular fingerprints of metronidazole-resistant strains of Helicobacter pylori from antral gastric mucosa. J Med Microbiol 1993; 38: 6-12
31. Ching CK, Leung KP, Yung RWH, et al. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 1996; 38: 675-8.
32. Roghani HS, Massarrat S, Pahlewanzadeh MR, Dashti M. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains. Eur J Gastroenterol Hepatol 1999; 11: 709-12.